Bank of Montreal’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bank of Montreal’s Portfolio VIRX Stock Details VIRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-140	Closed	-$210K	–	4207
2014 Q3	$210K	Sell	140 -267	-66%	-$387K	﹤0.01%	2517
2014 Q2	$557K	Buy	407 +90	+28%	+$104K	﹤0.01%	2024
2014 Q1	$440K	Buy	+317	New	+$369K	﹤0.01%	2122
2013 Q4	–	Sell	-24	Closed	-$25K	–	3959
2013 Q3	$25K	Sell	24 -219	-90%	-$234K	﹤0.01%	3137
2013 Q2	$265K	Buy	+243	New	+$271K	﹤0.01%	2055

Other funds holding VIRX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Bank of Montreal's VIRX Position: Q4 2014 in Review

Bank of Montreal sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q4 2014, closing a stake of 140 shares — an estimated $210K sold.

Bank of Montreal first reported a position in VIRX in Q2 2013 and held it in 5 quarters. The position peaked at $557K in Q2 2014. 78 funds tracked by Wall St. Rank hold VIRX as of Q4 2014.

Bank of Montreal reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
Bank of Montreal sold 140 Viracta Therapeutics, Inc. Common Stock shares in Q4 2014, an estimated $210K.
Bank of Montreal first reported a position in Viracta Therapeutics, Inc. Common Stock in Q2 2013 and held it in 5 quarters.
Bank of Montreal's Viracta Therapeutics, Inc. Common Stock position peaked at $557K in Q2 2014.
78 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q4 2014.

Based on Bank of Montreal's 13F filing for Q4 2014, filed 9 Feb 2015.